Targanta Therapeutics Corporation
(NASDAQ:TARG)|
0.960 +0.030 (3.23%) Jan 08 - Close |
|
|
|
After-Hours 0.98 +0.02 (2.08%) Thu, 8 Jan 2009 7:40 PM
- Compare TARG with:
- View: Line | Candlestick
Company Profile
Targanta Therapeutics Corporation
222 Third Street
Cambridge, MA 02142-1122
United States - Map
Phone: (617) 577-9020
Fax: (617) 577-9021
Website: www.targanta.com
State of incorporation: Delaware
CEO: Mark W. Leuchtenberger
Employees: 86
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Biopharmaceutical comp. of innovative antibiotics.
A biopharmaceutical company focused on developing and commercializing innovative antibiotics for serious infections treated or acquired in hospitals and other institutional settings.
Recent news for TARG
-
EDGAR Online - Dec 19 2008 at 4:21 ET
-
UPDATE - Targanta to cut 75 pct of workforce
Reuters - Dec 18 2008 at 5:11 ET
-
Briefing.com - Dec 18 2008 at 4:19 ET
-
Targanta Announces Corporate Restructuring
Business Wire - Dec 18 2008 at 4:05 ET
-
Forbes.com - Dec 09 2008 at 6:05 ET
-
FDA Declines to Approve Targanta Antibiotic
TheStreet.com - Dec 09 2008 at 5:10 ET
-
Rex Stores, Targanta Therapeutics: Biggest Price Decliners (RSC, TARG)
The Wall Street Journal Online - Dec 09 2008 at 4:54 ET
-
Movers roundup: Sprint Nextel, Targanta
AP - Dec 09 2008 at 2:40 ET
-
Pep Boys-Manny Moe & Jack, Targanta Therapeutics: Biggest Price Decliners (PBY, TARG)
The Wall Street Journal Online - Dec 09 2008 at 12:52 ET
-
UPDATE - FDA declines approval of Targanta's antibiotic
Reuters - Dec 09 2008 at 12:47 ET